Mitigation of Radiation Pneumonitis and Fibrosis
Sponsor: VA Office of Research and Development
Listed as NCT01754909, this PHASE2 trial focuses on Lung Cancer and Radiation Pneumonitis and remains completed. Sponsored by VA Office of Research and Development, it has been updated 13 times since 2013, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
13 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2023 — Jul 2024 [monthly]
Completed PHASE2
-
Dec 2022 — Jan 2023 [monthly]
Completed PHASE2
-
Jan 2021 — Dec 2022 [monthly]
Completed PHASE2
▶ Show 8 earlier versions
-
Nov 2019 — Jan 2021 [monthly]
Completed PHASE2
-
Jul 2018 — Nov 2019 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Jun 2018 — Jul 2018 [monthly]
Active Not Recruiting PHASE2
-
Jan 2018 — Jun 2018 [monthly]
Active Not Recruiting PHASE2
Status: Recruiting → Active Not Recruiting
-
Sep 2017 — Jan 2018 [monthly]
Recruiting PHASE2
-
Aug 2017 — Sep 2017 [monthly]
Recruiting PHASE2
-
Mar 2017 — Aug 2017 [monthly]
Recruiting PHASE2
-
Jan 2017 — Mar 2017 [monthly]
Recruiting PHASE2
First recorded
Nov 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- VA Office of Research and Development
For direct contact, visit the study record on ClinicalTrials.gov .